Annual Non Current Assets
$2.22 M
+$2.00 M+931.33%
01 July 2024
Summary:
BriaCell Therapeutics annual long term assets is currently $2.22 million, with the most recent change of +$2.00 million (+931.33%) on 01 July 2024. During the last 3 years, it has risen by +$1.97 million (+803.26%). BCTX annual non current assets is now -72.91% below its all-time high of $8.19 million, reached on 31 July 2012.BCTX Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$2.22 M
+$1.55 M+229.48%
01 July 2024
Summary:
BriaCell Therapeutics quarterly long term assets is currently $2.22 million, with the most recent change of +$1.55 million (+229.48%) on 01 July 2024. Over the past year, it has increased by +$2.01 million (+949.88%). BCTX quarterly non current assets is now -73.59% below its all-time high of $8.40 million, reached on 31 October 2012.BCTX Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCTX Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +931.3% | +949.9% |
| 3 y3 years | +803.3% | +817.5% |
| 5 y5 years | +703.5% | +773.0% |
BCTX Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +931.3% | at high | +949.9% |
| 5 y | 5 years | at high | +931.3% | at high | +949.9% |
| alltime | all time | -72.9% | -73.6% |
BriaCell Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| July 2024 | $3.65 M(-86.4%) | $2.22 M(+229.5%) |
| Apr 2024 | - | $673.30 K(+37.7%) |
| Jan 2024 | - | $489.10 K(+131.5%) |
| Oct 2023 | - | $211.30 K(-1.8%) |
| July 2023 | $26.95 M(-36.4%) | $215.10 K(-1.7%) |
| Apr 2023 | - | $218.90 K(-1.7%) |
| Jan 2023 | - | $222.70 K(-1.7%) |
| Oct 2022 | - | $226.50 K(-1.7%) |
| July 2022 | $42.35 M(-26.7%) | $230.30 K(-1.7%) |
| Apr 2022 | - | $234.20 K(-1.6%) |
| Jan 2022 | - | $238.00 K(-1.6%) |
| Oct 2021 | - | $241.80 K(-1.5%) |
| July 2021 | $57.80 M(>+9900.0%) | $245.60 K(-1.6%) |
| Apr 2021 | - | $249.60 K(+2.5%) |
| Jan 2021 | - | $243.40 K(+2.7%) |
| Oct 2020 | - | $237.00 K(-9.2%) |
| July 2020 | $261.50 K(+55.2%) | $260.90 K(+11.4%) |
| Apr 2020 | - | $234.30 K(-6.1%) |
| Jan 2020 | - | $249.60 K(-1.8%) |
| Oct 2019 | - | $254.10 K(-8.0%) |
| July 2019 | $168.50 K(-91.0%) | $276.10 K(-28.9%) |
| Apr 2019 | - | $388.10 K(-2.5%) |
| Jan 2019 | - | $398.00 K(-1.1%) |
| Oct 2018 | - | $402.40 K(-1.3%) |
| July 2018 | $1.88 M(+14.9%) | $407.50 K(+38.7%) |
| Apr 2018 | - | $293.70 K(-3.9%) |
| Jan 2018 | - | $305.70 K(+3.9%) |
| Oct 2017 | - | $294.10 K(>+9900.0%) |
| July 2017 | $1.63 M(+96.1%) | $1900.00(+11.8%) |
| Apr 2017 | - | $1700.00(-10.5%) |
| Jan 2017 | - | $1900.00(-9.5%) |
| Oct 2016 | - | $2100.00(-12.5%) |
| July 2016 | $833.30 K(-33.1%) | $2400.00(-14.3%) |
| Apr 2016 | - | $2800.00(-88.8%) |
| Jan 2016 | - | $24.90 K(-53.1%) |
| Oct 2015 | - | $53.10 K(+75.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| July 2015 | $1.25 M(+5113.0%) | $30.30 K(-28.5%) |
| Apr 2015 | - | $42.40 K(+88.4%) |
| Jan 2015 | - | $22.50 K(-51.7%) |
| Oct 2014 | - | $46.60 K(>+9900.0%) |
| July 2014 | $23.90 K(-98.4%) | $0.00(-100.0%) |
| Apr 2014 | - | $7.19 M(-4.6%) |
| Jan 2014 | - | $7.54 M(-5.0%) |
| Oct 2013 | - | $7.94 M(+0.2%) |
| July 2013 | $1.48 M(-30.4%) | $7.93 M(-1.7%) |
| Apr 2013 | - | $8.06 M(-0.7%) |
| Jan 2013 | - | $8.12 M(-3.3%) |
| Oct 2012 | - | $8.40 M(+2.6%) |
| July 2012 | $2.13 M(-59.0%) | $8.19 M(+11.0%) |
| Apr 2012 | - | $7.38 M(-0.1%) |
| Jan 2012 | - | $7.39 M(+0.4%) |
| Oct 2011 | - | $7.36 M(+2.9%) |
| July 2011 | $5.20 M(+276.8%) | $7.15 M(+41.0%) |
| Apr 2011 | - | $5.07 M(+2921.0%) |
| Jan 2011 | - | $167.80 K(+10.3%) |
| Oct 2010 | - | $152.10 K(+62.8%) |
| July 2010 | $1.38 M(+78.9%) | $93.40 K(-69.4%) |
| Apr 2010 | - | $305.30 K(+0.9%) |
| Jan 2010 | - | $302.70 K(-5.1%) |
| Oct 2009 | - | $319.00 K(+19.0%) |
| July 2009 | $770.70 K(+116.5%) | $268.00 K(+172.6%) |
| Apr 2009 | - | $98.30 K(+118.9%) |
| Jan 2009 | - | $44.90 K(-2.8%) |
| Oct 2008 | - | $46.20 K(+86.3%) |
| July 2008 | $356.00 K(-22.0%) | $24.80 K(>+9900.0%) |
| Apr 2008 | - | $0.00(0.0%) |
| Jan 2008 | - | $0.00(0.0%) |
| Oct 2007 | - | $0.00(0.0%) |
| July 2007 | $456.30 K(+416.2%) | $0.00(0.0%) |
| Apr 2007 | - | $0.00(0.0%) |
| Jan 2007 | - | $0.00(0.0%) |
| Oct 2006 | - | $0.00 |
| July 2006 | $88.40 K | - |
FAQ
- What is BriaCell Therapeutics annual long term assets?
- What is the all time high annual non current assets for BriaCell Therapeutics?
- What is BriaCell Therapeutics annual non current assets year-on-year change?
- What is BriaCell Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for BriaCell Therapeutics?
- What is BriaCell Therapeutics quarterly non current assets year-on-year change?
What is BriaCell Therapeutics annual long term assets?
The current annual non current assets of BCTX is $2.22 M
What is the all time high annual non current assets for BriaCell Therapeutics?
BriaCell Therapeutics all-time high annual long term assets is $8.19 M
What is BriaCell Therapeutics annual non current assets year-on-year change?
Over the past year, BCTX annual long term assets has changed by +$2.00 M (+931.33%)
What is BriaCell Therapeutics quarterly long term assets?
The current quarterly non current assets of BCTX is $2.22 M
What is the all time high quarterly non current assets for BriaCell Therapeutics?
BriaCell Therapeutics all-time high quarterly long term assets is $8.40 M
What is BriaCell Therapeutics quarterly non current assets year-on-year change?
Over the past year, BCTX quarterly long term assets has changed by +$2.01 M (+949.88%)